Nuveen Asset Management, LLC X Biotech Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in X Biotech Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 24,879 shares of XBIT stock, worth $71,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,879

Previous 24,879 -0.0%

Holding current value

$71,651

Previous $192,000 48.96%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$4.54 - $9.89 $112,950 - $246,053	24,879 New	24,879 $127,000
Q2 2022 Aug 15, 2022	SELL	$5.13 - $9.2 $453,492 - $813,279	-88,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.64 - $11.71 $21,064 - $28,548	2,438 Added 2.84%	88,400 $764,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $170,228 - $249,824	15,546 Added 22.08%	85,962 $957,000
Q3 2021 Nov 12, 2021	SELL	$12.95 - $18.24 $457,562 - $644,473	-35,333 Reduced 33.41%	70,416 $912,000
Q2 2021 Aug 16, 2021	BUY	$15.83 - $17.84 $500,607 - $564,172	31,624 Added 42.66%	105,749 $448,000
Q1 2021 May 17, 2021	SELL	$15.92 - $20.3 $134,205 - $171,129	-8,430 Reduced 10.21%	74,125 $1.15 Million
Q4 2020 Feb 16, 2021	BUY	$15.65 - $19.92 $116,749 - $148,603	7,460 Added 9.93%	82,555 $1.29 Million
Q3 2020 Nov 16, 2020	BUY	$13.97 - $21.16 $112,905 - $171,015	8,082 Added 12.06%	75,095 $1.43 Million
Q2 2020 Aug 14, 2020	BUY	$10.39 - $16.07 $58,028 - $89,750	5,585 Added 9.09%	67,013 $918,000
Q1 2020 May 14, 2020	SELL	$8.89 - $24.94 $104,848 - $294,142	-11,794 Reduced 16.11%	61,428 $652,000
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $129,506 - $310,162	15,547 Added 26.96%	73,222 $1.37 Million
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $99,017 - $150,979	14,434 Added 33.38%	57,675 $634,000
Q2 2019 Aug 15, 2019	BUY	$6.99 - $11.27 $302,254 - $487,326	43,241 New	43,241 $328,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.53M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $87.7M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC X Biotech Inc. Transaction History